The new cancer research research by memory sloping catering indicates the antique option for chemotherapy, surgery and some types of cancer.
According to a new survey published in the New England Journal of Medicine, about 80% of patients suffering from various types of cancer have successfully treated only with immunotherapy.
The immunotherapy protocol has successfully treated the rectal cancer patients 100% treating the trial.
The woman said that chatzipt helps detect cancer and saved her life, which doctors have missed
“My husband, Tommy and I were preparing for the worst,” in 2022 the gastrosophzial junction was suffering from cancer and later became the participant in the trial, Mourin Seedris remembered.
About 80% of patients who suffer from different types of cancer have successfully treated only with immunotherapy by predicting chemotherapy requirements. (Estock)
“After being treated only with immunotherapy, I had no evidence of cancer and would not have to do surgery, chemo or radiation,” he told MS in a press release. “I thought I won the lottery!”
Gastrointestinal oncologist Dr. Andrea Cerechek supervised the study with Dr. Luiz Diaz, a gastrointestinal oncologist.
Increases the risk of colorectal cancer in young people in contact with toxins, looking for study
According to the release, the pair sought to develop some of the traditional treated treatment due to the negative effects of the treatment.
The immunotherapy protocol has successfully treated patients with 100% treatment of rectal cancer patients. (Aaron Chown/PA Fig through the Getty Fig.)
“It is effective to treat surgery, radiation and chemotherapy quality care for rectal cancer treatment,” said Cerechek.
“But treatments can give people infertility and influence people as well as other aspects of daily life as well as in the intestines, urinary tract and sexual activity.”
“After being treated only with immunotherapy, I had no evidence of cancer and they didn’t have to have surgery, chemo or radiation.”
Participants in the test were all patients with tumors from all stages to stage 3, which means that the tumors have not yet spread, the release is indicated.
Dance can help relieve side effects related to cancer, initial data show
There was also a genetic mutation called Micach Repair-Ghatti (MMRD) with tumors, which made them especially weak for a type of immunotherapy called “checkpoint inhibitors”.
The checkpoint inhibitors, the participants supply the intuitively, “unmasc” tumors cells, make it easier for the body to fight them. (Estock)
This therapy tumor cells “Unmasks”, told MS that the patient’s own prevention system made the patient’s cancer cells easier to detect and kill.
The first clinical trial of therapy started with only 18 patients, each of whom had anal cancer.
Click here to get Fox News app
“We knew that there was a wide range of cancer here that had the same MMRD genetic conversion,” said Seresk. “We hope this approach can help people in the face of these other cancers.”
In the extended test, which contains 103 patients, there were 49 rectal cancer patients and 54 patients suffering from other types of cancer. Participants received the checkpoint inhibiter Infusion in the interconnectedly for six months according to the release.
Twenty -five patients with 54 patients with cancer except rectal cancer saw all the symptoms of their cancer disappeared after immunotherapy. (Estock)
There was no evidence of cancer after immunotherapy in all 49 rectal cancer patients.
All the symptoms of cancer have disappeared after 35 therapy in 54 patients with other cancers, according to various tests for research.
“This is a very important response, and the results were better than our expectations,” said Seresk. “We have found that some cancer types of colon and abdominal cancer have been very good in immunotherapy.”
Click here to sign up for our health newsletter
Ceresek said that 20% of non-reveal cancer patients who still need surgery after therapy have found that immunotherapy often shrinks tumors and even reduces the classification of some tumors, Sercec says.
Timothy Yap, Medical Oncologist at the University of Texas, MD, MD of the University of Texas, has agreed that the effectiveness of immunotherapy treatment for multiple types of cancer is “exciting”.
“Responsed patients can avoid the need for surgery, chemotherapy and radiation therapy for patients who responded and benefited by improving their quality of life.” (Estock)
“We are always trying to improve treatment for cancer patients through innovative clinical trials and this is no exception,” said Fox Digital, not involved in this study.
“Responding patients can avoid surgery, chemotherapy and radiation therapy and benefit by improving their living standards,” he said.
“This is a very important response, and the results were better than our expectation.”
On the basis of the main trial with rectal patients, the immunotherapy-cable system has been included in the treatment of the treatment of a wide cancer network, which is the doctor’s group that determines cancer treatment in the United States.
For more health articles, see www.foxnews.com/health
Multiple years after the first treatment, the original participants of the 2022 trial are still cancer free today.
Leave a Reply